References
- SUN Y., ZHANG L., CAI H., CHEN Y. Editorial: Osteoporosis, sarcopenia and muscle-bone crosstalk in COPD. Front Physiol. 2022; 13:1040693.
- BENZ E., et al. Sarcopenia in COPD: A systematic review and meta-analysis. Eur Respir Rev. 2019; 28(154).
- KALUŹNIAK-SZYMANOWSKA A., KRZYMIŃSKA-SIEMASZKO R., DESKUR-ŚMIELECKA E., LEWANDOWICZ M., KACZMAREK B., WIECZOROWSKA-TOBIS K. Malnutrition, sarcopenia, and malnutrition-sarcopenia syndrome in older adults with COPD. Nutrients. 2022; 14(1).
- XIANG Y., LUO X. Extrapulmonary comorbidities associated with chronic obstructive pulmonary disease: A review. Int J Chron Obstruct Pulmon Dis. 2024; 19:567–78.
- CRUZ-JENTOFT A.J., et al. Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing. 2019; 48(1):16–31.
- BAUER J., et al. Sarcopenia: A time for action. An SCWD position paper. J Cachexia Sarcopenia Muscle. 2019; 10(5):956–61.
- VAN BAKEL S.I.J., GOSKER H.R., LANGEN R.C., SCHOLS A.M.W.J. Towards personalized management of sarcopenia in COPD. 2021.
- LOCQUET M., BRUYÈRE O., LENGELÉ L., REGINSTER J.Y., BEAUDART C. Relationship between smoking and the incidence of sarcopenia: The SarcoPhAge cohort. Public Health. 2021; 193:101–8.
- ZHOU J., et al. Risk factors of sarcopenia in COPD patients: A meta-analysis. Int J Chron Obstruct Pulmon Dis. 2024; 19:1613–22.
- TRAJANOSKA K., et al. Sarcopenia and its clinical correlates in the general population: The Rotterdam Study. J Bone Miner Res. 2018; 33(7):1209–18.
- GLOBAL INITIATIVE FOR CHRONIC OBSTRUCTIVE LUNG DISEASE. Global Initiative for Chronic Obstructive Lung Disease – GOLD. 2024.
- MALTAIS F., et al. An official American Thoracic Society/European Respiratory Society statement: update on limb muscle dysfunction in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2014; 189(9).
- BARREIRO E., JAITOVICH A. Muscle atrophy in chronic obstructive pulmonary disease: molecular basis and potential therapeutic targets. J Thorac Dis. 2018; 10(Suppl 12):S1415–24.
- HENROT P., et al. Main pathogenic mechanisms and recent advances in COPD peripheral skeletal muscle wasting. Int J Mol Sci. 2023; 24(7).
- SHARANYA A., CIANO M., WITHANA S., KEMP P.R., POLKEY M.I., SATHYAPALA S.A. Sex differences in COPD-related quadriceps muscle dysfunction and fibre abnormalities. Chron Respir Dis. 2019; 16.
- BONE A.E., HEPGUL N., KON S., MADDOCKS M. Sarcopenia and frailty in chronic respiratory disease: lessons from gerontology. 2017.
- KIM S.H., SHIN M.J., SHIN Y.B., KIM K.U. Sarcopenia associated with chronic obstructive pulmonary disease. J Bone Metab. 2019;26(2):65–74.
- MA K., HUANG F., QIAO R., MIAO L. Pathogenesis of sarcopenia in chronic obstructive pulmonary disease. Front Physiol. 2022; 13:850964.
- DA COSTA T.M.R.L., COSTA F.M., MOREIRA C.A., RABELO L.M., BOGUSZEWSKI C.L., BORBA V.Z.C. Sarcopenia in COPD: relationship with COPD severity and prognosis. J Bras Pneumol. 2015; 41(5):415–21.
- ATEŞ F., MARQUETAND J., ZIMMER M. Detecting age-related changes in skeletal muscle mechanics using ultrasound shear wave elastography. Sci Rep. 2023; 13(1):20062.
- ZHANG L., SUN Y. Muscle-bone crosstalk in chronic obstructive pulmonary disease. Front Endocrinol (Lausanne). 2021; 12.
- MANCEAU M., et al. Myostatin promotes the terminal differentiation of embryonic muscle progenitors. Genes Dev. 2008; 22(5):668–81.
- SANCHO-MUÑOZ A., GUITART M., RODRÍGUEZ D.A., GEA J., MARTÍNEZ-LLLORENS J., BARREIRO E. Deficient muscle regeneration potential in sarcopenic COPD patients: role of satellite cells. J Cell Physiol. 2021; 236(4):3083–98.
- CAVAILLÈS A., et al. Comorbidities of COPD. Eur Respir Rev. 2013; 22(130):454–75.
- Y M, DAVE A.K., PATEL S.S., PARBAT R., SHAH V., GANDHI R. Association between sarcopenia and chronic renal failure (overt and concealed) in chronic obstructive pulmonary disease (COPD) patients: a cross-sectional study. Cureus. 2023; 15(10).
- VESTBO J., et al. Body mass, fat-free body mass, and prognosis in patients with chronic obstructive pulmonary disease from a random population sample: findings from the Copenhagen City Heart Study. Am J Respir Crit Care Med. 2006; 173(1):79–83.
- VERMEEREN M.A.P., et al. Prevalence of nutritional depletion in a large outpatient population of patients with COPD. Respir Med. 2006; 100(8):1349–55.
- RUTTEN E.P.A., et al. Quantitative CT: associations between emphysema, airway wall thickness and body composition in COPD. Pulm Med. 2011; 2011:419328.
- DONINI L.M., et al. Definition and diagnostic criteria for sarcopenic obesity: ESPEN and EASO consensus statement. Obes Facts. 2022; 15(3):321.
- OZCAKIR S., SIGIRLI D., URSAVAS A., UZASLAN E. COPD and osteoporosis: associated factors in patients treated with inhaled corticosteroids. Int J Chron Obstruct Pulmon Dis. 2020; 15:2441–48.
- LEDUC-GAUDET J.P., HUSSAIN S.N.A. Muscle wasting in chronic obstructive pulmonary disease: not enough autophagy? Am J Respir Cell Mol Biol. 2022; 66(6):587–88.
- BAHAT G., OREN M.M., YILMAZ O., KILIÇ C., AYDIN K., KARAN M.A. Comparing SARC-F with SARC-CalF to screen sarcopenia in community living older adults. J Nutr Health Aging. 2018; 22(9):1034–38.
- CHO M.-R., LEE S., SONG S.-K. A review of sarcopenia pathophysiology, diagnosis, treatment and future direction. J Korean Med Sci. 2022; 37(18).
- YUAN S., LARSSON S.C. Epidemiology of sarcopenia: prevalence, risk factors, and consequences. Metabolism. 2023; 144.
- VAN ANCUM J.M., ALCAZAR J., MESKERS C.G.M., NIELSEN B.R., SUETTA C., MAIER A.B. Impact of using the updated EWGSOP2 definition in diagnosing sarcopenia: a clinical perspective. Arch Gerontol Geriatr. 2020; 90.
- FERNANDES S., et al. Cutoff points for grip strength in screening for sarcopenia in community-dwelling older adults: a systematic review. J Nutr Health Aging. 2022; 26(5):452–60.
- PAPADOPOULOU S.K., TSINTAVIS P., POTSAKI G., PAPANDREOU D. Differences in the prevalence of sarcopenia in community-dwelling, nursing home and hospitalized individuals: a systematic review and meta-analysis. J Nutr Health Aging. 2020; 24(1):83–90.
- SHAFIEE G., KESHTKAR A., SOLTANI A., AHADI Z., LARIJANI B., HESHMAT R. Prevalence of sarcopenia in the world: a systematic review and meta-analysis of general population studies. J Diabetes Metab Disord. 2017; 16(1):1–10.
- ACHAMRAH N., et al. Comparison of body composition assessment by DXA and BIA according to the body mass index: a retrospective study on 3655 measures. PLoS One. 2018; 13(7):e0200465.
- SEPÚLVEDA-LOYOLA W., OSADNIK C., PHU S., MORITA A.A., DUQUE G., PROBST V.S. Diagnosis, prevalence, and clinical impact of sarcopenia in COPD: a systematic review and meta-analysis. 2020.
- MATKOVIC Z., et al. Easy to perform physical performance tests to identify COPD patients with low physical activity in clinical practice. Int J Chron Obstruct Pulmon Dis. 2020; 15:921–29.